Tempo Therapeutics’ $12 Million Series A Financing Round

Leila Ahmed
Tagged:

Wilson Sonsini Goodrich & Rosati represented Tempo Therapeutics in the transaction.Tempo Therapeutics, Inc. (“Tempo”) announced the completion of a $12 million Series A equity financing round, led by Galaxy-Sirius…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now